Effect of BSA Antigen Sensitization during the Acute Phase of Influenza A Viral Infection on CD11c+ Pulmonary Antigen Presenting Cells  by Sato, Fumitaka et al.
Allergology International Vol 58, No3, 2009 www.jsaweb.jp 445
Effect of BSA Antigen Sensitization
during the Acute Phase of Influenza A
Viral Infection on CD11c+ Pulmonary
Antigen Presenting Cells
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ABSTRACT
Background: Influenza A viral infection is concerned with induction of asthma. CD11c+ pulmonary antigen
presenting cells (APCs) play a central role in sensitization with inhaled antigens during the acute phase of influ-
enza A viral infection and also reside on bronchial epithelium for the long term after sensitization. To investigate
the role of CD11c+ pulmonary APCs in the inhaled antigen sensitization during the acute phase of influenza A
viral infection, we analyzed their function.
Methods: Mice were infected with influenza A virus and were sensitized intranasally with BSAalum during the
acute phase of influenza A viral infection. Expression of surface antigens on CD11c+ pulmonary APCs was
analyzed by FACS. Cytokine production from CD11c+ pulmonary APCs, and interaction between CD11c+ pul-
monary APCs and naïve CD4+ T cells was assessed by ELISA. Ability of antigen presentation by CD11c+ pul-
monary APCs was measured by proliferation assay.
Results: BSA antigen sensitization during the acute phase of influenza A viral infection induced eosinophil re-
cruitment into the lungs after BSA antigen challenge and moderately increased expression of MHC class II
molecules on CD11c+ pulmonary APCs. The interaction between the CD11c+ pulmonary APCs and naïve
CD4+ T cells secreted large amounts of IL-10.
Conclusions: BSA antigen sensitization during the acute phase of influenza A viral infection enhanced IL-10
production from naïve CD4+ T cell interaction with CD11c+ pulmonary APCs. The IL-10 secretion evoked Th2
responses in the lungs with downregulation of Th1 responses and was important for the eosinophil recruitment
into the lungs after BSA antigen challenge.
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INTRODUCTION
Respiratory viral infections are a major factor for the
induction and the exacerbation of asthma in infants
and in adults.1-3 Respiratory syncytial virus (RSV) re-
infection in neonates is responsible for the develop-
ment of airway hyperresponsiveness (AHR) and air-
way eosinophilia via IL-13-dependent pathways.4
Schwarze et al. showed that infection with RSV in-
duces an IL-5-dependent accumulation of eosinophils
as a part of the acute inflammatory response in a
mouse model.5 On the other hand, influenza A viral
infection leads to the local IFN-γ production by virus-
specific T cells with absence of eosinophils for the
acute inflammatory response in the lungs.6-8 Al-
though IFN-γ is known to suppress the differentiation
and proliferation of Th2 cells both in vitro and in
vivo,9,10 several investigators indicated that inhaled
antigen sensitization during the acute phase of influ-
enza A viral infection is associated with the induction
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of asthma mediated by Th2 responses.11-13 In the
model of asthma with influenza A viral infection, den-
dritic cells (DCs) are essential for the induction of
Th2 responses.12,13
DCs are distributed throughout the lungs, play an
important role in antigen presentation, and induce a
primary immune response to inhaled antigens. DCs
capture inhaled antigens in the airway and migrate to
the draining mediastinal lymph nodes, where they
move into T cell zones and interact with naïve T cells
to initiate antigen-specific immune responses.14-17 DC
maturation occurs following antigen uptake and re-
sults in the increased expression of the major histo-
compatibility complex (MHC) class II and costimula-
tory molecules, such as CD8086 and CD40.18 Also,
DCs are associated with the polarization of naïve
CD4+ T cells toward Th1 or Th2 cells. The Th1Th2
cell differentiation of naïve T cells is influenced by the
cytokine milieu and the strength of interaction be-
tween DCs and naïve T cells.9,19,20 DCs produce large
amounts of IL-12 in response to viral and bacterial
stimulation mediated Toll-like receptors. IL-12 se-
creted by DCs drives polarization toward Th1 cells
through binding to IL-12 receptor on naïve T cells.9,21
Similar to IL-12, IFN-γ plays a central role in the dif-
ferentiation of Th1 cells.9 Moreover, high avidity in-
teraction between MHC-peptide complex and T cell
receptor (TCR) promotes Th1 cells.22 In contrast, IL-
10 produced by DCs polarizes naïve T cells toward
Th2 cells and inhibits the development of Th1 cells.23
IL-4 production by Th2 cells also enhances the differ-
entiation of naïve T cells toward Th2 cells. Weak
TCR-MHC class II interaction between DCs and T
cells is thought to induce IL-4-producing T cells.22
We have demonstrated that influenza A viral infec-
tion enhances the airway sensitization of a suboptimal
concentration of antigen. Moreover, influenza A viral
infection induced the migration of DCs into the bron-
chial epithelium, and these migrated cells were es-
sential for the sensitization.24,25 However, the exact
mechanisms of DCs for inhaled antigen sensitization
during the acute phase of influenza A viral infection
remain still unclear. To investigate how DCs affect on
antigen sensitization during the acute phase of influ-
enza A viral infection, we analyzed the function of
CD11c+ pulmonary APCs in the asthmatic mouse
model.
METHODS
MICE
Female C57BL6 mice were purchased from Japan
SLC (Shizuoka, Japan). Ovalbumin (OVA)323-339 spe-
cific TCR-transgenic (OT-II) mice on a C57BL6
background were obtained from Jackson Laboratory
(Bar Harbor, ME, USA). Animals were fed with OVA
free diets and water ad libitum and were kept under
special pathogen-free conditions in a laminar flow
container. Experimental protocols were approved by
the Institutional Animal Care and Use Committee of
Yokohama City University School of Medicine.
INFLUENZA A VIRAL INFECTION
The mouse-adapted strain of influenza APR834
(PR8, H1N1) virus was prepared as previously de-
scribed (Suzuki et al.).24 Influenza A virus diluted
with PBS at a titer of 2 × 103 PFUml, which showed
virus illumination from day 7 to day 10, was used for
infection. Mice were inoculated intranasally with
30 μl of virus solution under anesthesia with diethyl
ether.
ALLERGEN SENSITIZATION AND CHALLENGE
Mice were sensitized with aerosolized bovine serum
albumin (BSA) (Sigma, St. Louis, MO, USA) solution
that was dissolved in PBS at a concentration of 500
μgml BSA including 5 mgml alum adjuvant
(PIERCE, Rockford, IL, USA) for 30 minutes using a
DeVilbiss 646 nebulizer (Somerset, PA, USA) during
days 3 to 7 after influenza A viral infection. Mice were
challenged with aerosolized BSA solution (20 mgml
BSA in sterilized PBS) for 30 minutes using a DeVil-
biss 646 nebulizer during days 28 to 32 after influenza
A viral infection.
EXPERIMENTAL GROUPS
The experimental groups were as follows. (I) The
control group including mice that were not inoculated
with virus on day 0 and were not sensitized with
BSAalum on days 3 to 7. (II) The BSA group includ-
ing mice that were not inoculated with virus on day 0
and were sensitized with BSAalum on days 3 to 7.
(III) The virus group including mice that were inocu-
lated with virus on day 0 and were not sensitized with
BSAalum on days 3 to 7. (IV) The virus + BSA group
including mice that were inoculated with virus on day
0 and were sensitized with BSAalum on days 3 to 7.
BRONCHOALVEOLAR LAVAGE FLUID (BALF)
Mice were lavaged with 0.8 ml PBS 4 times under an-
esthesia with pentobarbital sodium (40 mgkg body
weight, Kyoritsu Seiyaku, Tokyo, Japan) on day 34.
Cells in the fluid were counted and then were stained
with Diff-Quick (International Reagent, Kobe, Japan)
for analysis of different leukocyte types. The differen-
tial cell count was determined by counting 200 cells
under a light microscope.
FLOW CYTOMETRIC ANALYSIS
The following antibodies (Abs) were used in this
study; fluorescein isothiocyanate (FITC)-conjugated
anti-mouse CD11c mAb (BD Biosciences, San Diego,
CA, USA), FITC-conjugated anti-mouse CD86 mAb
(eBioscience, San Diego, CA, USA), phycoerythrin
(PE)-conjugated anti-mouse MHC class II mAb
(Southern Biotechnology Associates Inc., Birming-
ham, AL, USA), PE-conjugated anti-mouse CD80
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mAb (eBioscience), biotinylated anti-mouse CD40
mAb (eBioscience), biotinylated anti-mouse CD11c
mAb (eBioscience), biotinylated anti-mouse CD11b
mAb (eBioscience), and PE CyCrome 5 (PC5)-
conjugated streptavidin (Beckman Coulter, Fullerton,
CA, USA). Cells (2 × 106) were stained with Abs de-
scribed above and were analyzed by FACScan flow
cytometer with Cell-Quest Software (BD Biosciences,
San Jose, CA, USA).
CELL PREPARATION
To isolate CD11c+ pulmonary APCs, mice were killed
at 10 days after influenza A virus infection. Then,
lungs were perfused with saline and were minced in
RPMI1640 medium (Gibco, Langley, OK, USA) con-
taining 2 mM L-glutamine (Wako, Osaka, Japan), 200
μgml streptomycin (Meiji, Tokyo, Japan), and 200
Uml penicillin (Meiji). These were added with same
volume of RPMI1640 medium containing 6% FCS
(Biological Industries, Haemek, Israel), 0.4% collage-
nase (Wako), and 200 μgml DNase I (Roche,
Mannheim, Germany) for digestion. After digestion,
the pieces of lungs were ground with glass slides.
Mononuclear cells in the single cell suspension of
lungs were collected by Percoll (GE Healthcare Bio-
Science Corp., Piscataway, NJ, USA) gradient cen-
trifugation. CD11c+ cells were positively selected by
auto-MACS using anti-mouse CD11c MicroBeads
(Miltenyi Biotec, Auburn, CA, USA). The purity of
CD11c+ cells from lungs was more than 95% accord-
ing to FACS analysis.
To isolate naïve CD4+ T cells from spleen of OT-II
mice (OT-II T cells), spleen was ground with glass
slides. The single cell suspension was passed
through a nylon fiber column to remove MHC class
II+ cells. OT-II T cells were positively selected by
auto-MACS using biotinylated anti-mouse CD4 mAb
(eBioscience) and anti-biotin MicroBeads (Miltenyi
Biotec). The purity of CD4+ cells from spleen of OT-II
mice was more than 95% according to FACS analysis.
CYTOKINE PRODUCTION FROM CD11c+ PUL-
MONARY APCs
CD11c+ pulmonary APCs (5 × 105 cellswell) were
cultured in 96-well flat-bottom plates in culture me-
dium (RPMI1640 medium supplemented with 10%
FCS, 2 mM L-glutamine, 200 μgml streptomycin,
200 Uml penicillin, 10 mM HEPES [Dojindo, Ku-
mamoto, Japan], and 50 μM Mercaptoethanol
[Wako]) and were stimulated with 1 μgml lipopoly-
saccharide (LPS) (Sigma) for 48 hours. The culture
supernatant was collected and was kept at −80℃ until
examined.
PROLIFERATION ASSAY
OT-II T cells (4 × 105 cellswell) were cultured with
irradiated CD11c+ pulmonary APCs (1 × 105, 4 × 104,
8 × 103 cellswell) and 100 μgml OVA (Sigma) in 96-
well flat-bottom plates in the culture medium for 72
hours. To assess the cell proliferation, [3H]-labeled
thymidine (0.5 μCiwell) was added for the last 8
hours and the incorporated radioactivity was meas-
ured by a Betaplate scintillation counter (Beckman
Coulter). All proliferation data represented the aver-
age of cpm in triplicate determinations.
CYTOKINE PRODUCTION FROM THE INTERAC-
TION BETWEEN CD11c+ PULMONARY APCs
AND OT-II T CELLS
OT-II T cells (4 × 105 cellswell) were cultured with
CD11c+ pulmonary APCs (1 × 105 cellswell) and 100
μgml OVA in 96-well flat-bottom plates in the culture
medium for 72 hours. The culture supernatant was
collected and was kept −80℃ until examined.
CYTOKINE ELISAs
Amounts of cytokines in the culture supernatant were
determined by IL-4, IFN-γ, and IL-10 ELISA kit ac-
cording to manufacturer’s instructions (eBioscience).
Plates were read on a microplate reader (BIO-RAD,
Hercules, CA, USA) at a wavelength of 405 nm. The
amounts of cytokine were determined by comparing
sample values to the linear portion of the standard
curve.
STATISTICAL ANALYSIS
Statistical significance of differences between experi-
mental groups was determined by the Student’s t-test.
RESULTS
BSA ANTIGEN SENSITIZATION DURING THE
ACUTE PHASE OF INFLUENZA A VIRAL INFEC-
TION RECRUITED EOSINOPHILS INTO THE
LUNGS AFTER BSA ANTIGEN CHALLENGE
We have shown previously that inhaled antigen sensi-
tization during the acute phase of influenza A viral in-
fection is involved in the induction of asthma.24,25 We
first examined the number of macrophages, lympho-
cytes, and eosinophils in BALF from each group,
which were proceeded using methods indicated in
Figure 1a. Mice from the virus + BSA group showed
an increased number of macrophages, lymphocytes,
and eosinophils into the lungs after BSA antigen chal-
lenge. On the other hand, mice from the control
group, the BSA group, and the virus group did not en-
hance the eosinophil recruitment into the lungs after
BSA antigen challenge (Table 1).
BSA ANTIGEN SENSITIZATION DURING THE
ACUTE PHASE OF INFLUENZA A VIRAL INFEC-
TION ALTERED THE EXPRESSION OF MHC
CLASS II MOLECULES ON CD11c+ PULMONARY
APCs
We investigated whether BSA antigen sensitization
during the acute phase of influenza A viral infection
modify the expression of surface antigens on CD11c+
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Table 1 The number of macrophages, lymphocytes, and 
eosinophils in BALF from each group after antigen 
chalenge.
Eosinophils
(×103)
Lymphocytes
(×103)
Macrophages
(×103)Group
0.0 ± 0.0 0.5 ± 0.4 29.1 ± 0.4Control
0.0 ± 0.0 4.4 ± 3.9 42.8 ± 3.8BSA
0.0 ± 0.0 3.8 ± 3.0 43.0 ± 3.0Virus
4.5 ± 4.0*27.9 ± 22.7*100.8 ± 22.7*Virus + BSA
Mice (n = 5 per group) were inoculated with influenza A virus 
or not at day 0 and were sensitized with BSA/alum or not during 
days 3 to 7. Mice from al groups were chalenged with BSA dur-
ing days 28 to 32 and were lavaged with PBS under anesthesia 
48h after the last antigen chalenge. Cels in BALF were 
counted and were assessed by Dif-Quick staining. Data are 
representative of three independent experiments. *p < 0.05 
compared with the control group or the virus group.
Fig. 1 Summary of influenza A viral infection, BSA sensitization, and BSA 
chalenge protocols. (a) Mice were inoculated with influenza A virus or not in-
oculated at day 0 and were sensitized with BSA or not sensitized during days 3 
to 7. Mice from al groups were chalenged with BSA during days 28 to 32 and 
were lavaged with PBS under anesthesia 48 hours after the last BSA antigen 
chalenge. (b) Mice were inoculated with influenza A virus or not inoculated at 
day 0 and were sensitized with BSA or not sensitized during days 3 to 7. 
CD11c+ pulmonary APCs from each group were isolated by auto-MACS using 
anti-mouse CD11c MicroBeads at day 10.
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Analysis of CD11c+ APC function
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b
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+--Control
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pulmonary APCs isolated at 10 days after influenza A
viral infection. Details of each group are shown in
Figure 1b. CD11c+ pulmonary APCs from the virus +
BSA group showed increased expression of MHC
class II, CD40, and CD11b molecules when compared
with those of the control group. However, CD80 and
CD86 expression on CD11c+ pulmonary APCs
showed no difference between either groups. CD11c+
pulmonary APCs from the virus + BSA group and the
virus group expressed similar levels of CD80, CD86,
CD40, and CD11b. On the other hand, CD11c+ pul-
monary APCs from the virus + BSA group showed de-
creased expression of MHC class II molecules as-
sessed by mean fluorescence intensity (MFI) when
compared with those from the virus group (Fig. 2).
CD11c+ pulmonary APCs from the BSA group
showed similar expression levels of MHC class II,
CD40, CD11b, CD80, and CD86 molecules compared
with those from the control group (data not shown).
Role of APCs in Airway Inflammation
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Fig. 2 Influenza A viral infection enhanced the expression of MHC class I, CD40, and CD11b mole-
cules on CD11c+ pulmonary APCs. BSA antigen sensitization during the acute phase of influenza A vi-
ral infection showed a moderate expression of MHC class I molecules on CD11c+ pulmonary APCs. 
CD11c+ pulmonary APCs were positively selected by auto-MACS using anti-mouse CD11c 
MicroBeads. Cels were stained with PE-conjugated anti-mouse MHC class I mAb, PE-conjugated 
anti-mouse CD80 mAb, FITC-conjugated anti-mouse CD86 mAb, biotinylated anti-mouse CD40 mAb, 
biotinylated anti-mouse CD11b mAb, and PC5-conjugated streptavidin and were analyzed by flow 
cytometry. Three to 10 mice were used in each experimental group. Control group; open histograms 
with dashed lines, Virus group; shaded histograms with thin lines, Virus + BSA group; open histo-
grams with bold lines. The mean fluorescence intensity is shown in histograms. Data are representa-
tive of three independent experiments.
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These results indicated that influenza A viral infection
increased the expression of MHC class II, CD40, and
CD11b molecules on the surface of CD11c+ pulmo-
nary APCs. BSA antigen sensitization during the
acute phase of influenza A viral infection decreased
the expression levels of MHC class II molecules on
CD11c+ pulmonary APCs.
INFLUENZA A VIRAL INFECTION ENHANCED
THE ABILITY OF ANTIGEN PRESENTATION BY
CD11c+ PULMONARY APCs
We next determined whether the different expres-
sion levels of MHC class II molecules on CD11c+ pul-
monary APCs from between the virus + BSA group
and the virus group affect the ability of antigen pres-
entation. CD11c+ pulmonary APCs were isolated at 10
days after influenza A viral infection. Details of each
group were shown in Figure 1b. Naïve CD4+ T cells
from OT-II mice were stimulated with CD11c+ pulmo-
nary APCs from each group in the presence of OVA.
As expected, CD11c+ pulmonary APCs from the vi-
rus + BSA group and the virus group significantly
stimulated OT-II T cells compared with those from
the control group. CD11c+ pulmonary APCs from the
virus + BSA group and the virus group showed simi-
lar ability to proliferate OT-II T cells (Fig. 3). The
ability of antigen presentation by CD11c+ pulmonary
APCs from the BSA group was comparable when
compared with those from the control group (data
not shown). These results demonstrated that influ-
enza A viral infection enhanced the function of CD11c
+ pulmonary APCs in the proliferation of naïve CD4+
T cells. BSA antigen sensitization during the acute
phase of influenza A viral infection did not alter the
ability of antigen presentation by CD11c+ pulmonary
APCs, although the expression levels of MHC class II
molecules was different between CD11c+ pulmonary
APCs from the virus + BSA group and the virus
group.
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Fig. 3 Influenza A viral infection enhanced ability of anti-
gen presentation of CD11c+ pulmonary APCs. Naïve CD4+ 
T cels (4 × 105 cels/wel) from OT-I mice were cultured 
with iradiated CD11c+ pulmonary APCs at indicated num-
ber from each group in the presence of OVA (100 μg/ml) for 
72 hours. Three to 10 mice were used in each experimental 
group. Control group; white bar, Virus group; gray bar, 
Virus + BSA group; black bar. Cel proliferation was as-
sessed by incorporation of [3H]-labeled thymidine in T cels. 
The results are expressed as mean cpm of triplicates ± SD. 
Data are representative of three independent experiments.  
* p < 0.05,  ** p < 0.01.
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BSA ANTIGEN SENSITIZATION DURING THE
ACUTE PHASE OF INFLUENZA A VIRAL INFEC-
TION INDUCED INCREASED AMOUNTS OF IL-10
AND IFN-γ PRODUCTION FROM CD11c+ PULMO-
NARY APCs
We next determined if BSA antigen sensitization dur-
ing the acute phase of influenza A viral infection af-
fected cytokine production from CD11c+ pulmonary
APCs isolated at 10 days after influenza A viral infec-
tion. Details of each group are shown in Figure 1b.
To assess the amounts of their cytokine secretion,
they were stimulated with LPS. CD11c+ pulmonary
APCs from the virus + BSA group showed signifi-
cantly larger amounts of IL-10 and IFN-γ secretion
when compared with those from the control group.
CD11c+ pulmonary APCs from the virus + BSA group
produced slightly but not significantly higher
amounts of IL-10 compared with those from the virus
group.
However, CD11c+ pulmonary APCs from the virus
+ BSA group produced significantly larger amounts of
IFN-γ than those from the virus group. CD11c+ pul-
monary APCs from the virus group secreted signifi-
cantly larger amounts of IL-10 than those from the
control group, although IFN-γ production from both
CD11c+ pulmonary APCs showed no difference (Fig.
4). CD11c+ pulmonary APCs from the BSA group
showed similar ability to secret IL-10 and IFN-γ com-
pared with those from the control group (data not
shown). These data suggested that influenza A viral
infection enhanced IL-10 production from CD11c+
pulmonary APCs. BSA antigen sensitization during
the acute phase of influenza A viral infection led to in-
creased IFN-γ secretion from CD11c+ pulmonary
APCs.
BSA ANTIGEN SENSITIZATION DURING THE
ACUTE PHASE OF INFLUENZA A VIRAL INFEC-
TION ENHANCED IL-10 PRODUCTION FROM IN-
TERACTION BETWEEN CD11c+ PULMONARY
APCs AND NAïVE CD4+ T CELLS
We next determined whether the interaction between
CD11c+ pulmonary APCs from each group and naïve
CD4+ T cells from OT-II mice lead to a different cy-
tokine milieu. CD11c+ pulmonary APCs were isolated
at 10 days after influenza A viral infection. Details of
each group are shown in Figure 1b. OT-II T cells
were cultured with CD11c+ pulmonary APCs from
each group in the presence of OVA. The amounts of
IL-4 in culture supernatant from OT-II T cells cul-
tured with CD11c+ pulmonary APCs from each group
were comparable. Interestingly, the interaction be-
tween CD11c+ pulmonary APCs from the virus + BSA
group and OT-II T cells induced similar ability of IFN-
γ production compared with that between CD11c+
pulmonary APCs from the control group and OT-II T
cells, and slightly but not significantly less IFN-γ se-
cretion than that between CD11c+ pulmonary APCs
from the virus group and OT-II T cells, although
CD11c+ pulmonary APCs from the virus + BSA group
had significantly larger amounts of IFN-γ production
than those from the control group and the virus
group as shown in Figure 4 (Fig. 5a). The culture su-
pernatant from OT-II T cells cultured with CD11c+
pulmonary APCs from the virus + BSA group or the
virus group showed significantly larger amounts of
IL-10 than that from OT-II T cells cultured with CD11
c+ pulmonary APCs from the control group. More-
over, IL-10 production by OT-II T cells cultured with
CD11c+ pulmonary APCs from the virus + BSA group
was significantly high compared to that by OT-II T
cells cultured with CD11c+ pulmonary APCs from the
virus group (Fig. 5b). The interaction between
CD11c+ pulmonary APCs from the BSA group and
OT-II T cells secreted similar amounts of IL-4, IFN-γ,
and IL-10 compared with that between CD11c+ pul-
monary APCs from the control group and OT-II T
cells (data not shown). These results indicated that
BSA antigen sensitization during the acute phase of
influenza A viral infection enhanced IL-10 production
Role of APCs in Airway Inflammation
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Fig. 4 BSA antigen sensitization during the acute phase of influenza A vi-
ral infection induced large amounts of IL-10 and IFN-γ production from 
CD11c+ pulmonary APCs. CD11c+ pulmonary APCs (5 × 105 cels/wel) 
were cultured with LPS (1 μg/ml) for 48 hours. Three to 10 mice were used 
in each experimental group. Control group; white bar, Virus group; gray 
bar, Virus + BSA group; black bar. The culture supernatant was colected 
and the amounts of IL-10 and IFN-γ were assessed by ELISA kit. * p < 0.05, 
**p < 0.01.
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by the interaction CD11c+ pulmonary APCs and naïve
CD4+ T cells. On the other hand, CD11c+ pulmonary
APCs with influenza A viral infection alone differenti-
ated naïve CD4+ T cells into IFN-γ-secreting T cells.
DISCUSSION
In this study, we showed that BSA antigen sensitiza-
tion during the acute phase of influenza A viral infec-
tion recruited eosinophils into the lungs after BSA an-
tigen challenge (Table 1). Influenza A viral infection
increased the expression of MHC class II, CD40, and
CD11b molecules on the surface of CD11c+ pulmo-
nary APCs and enhanced IL-10 production from
CD11c+ pulmonary APCs (Fig. 2 and Fig. 4). Influ-
enza A viral infection also promoted CD11c+ pulmo-
nary APCs to effectively polarize naïve T cells toward
IFN-γ-secreting T cells (Fig. 5a). On the other hand,
BSA antigen sensitization during the acute phase of
influenza A viral infection led CD11c+ pulmonary
APCs to express moderate levels of MHC class II
molecules (Fig. 2). CD11c+ pulmonary APCs from the
virus + BSA group showed the highest ability to se-
cret IL-10 and IFN-γ among those from three groups
(Fig. 4). Moreover, the interaction between CD11c+
pulmonary APCs from the virus + BSA group and
naïve CD4+ T cells induced more IL-10 production
compared with that between CD11c+ pulmonary
APCs from the virus group and naïve CD4+ T cells
(Fig. 5b). These data demonstrated that BSA antigen
sensitization during the acute phase of influenza A vi-
ral infection is a key factor for the eosinophil recruit-
ment into the lungs after BSA antigen challenge and
may alter Th2-promoting environments in the lungs
by downregulation of the Th1 response mediated by
IL-10 production from the interaction between
CD11c+ pulmonary APCs and naïve CD4+ T cells.
APCs lead to either tolerance or active immune re-
sponse against antigens by expression of MHC and
costimulatory molecules on them.18 In the lungs,
CD11c+ APCs are characterized by decreased expres-
sion of MHC and costimulatory molecules, and induc-
tion of tolerance at a steady state. Because the respi-
ratory tract is constantly exposed by many innocuous
antigens, the peripheral immune system has evolved
several mechanisms to maintain a state of tolerance
to innocuous antigens in the lungs.26,27 In this study,
CD11c+ pulmonary APCs from the control group
showed low expression of MHC class II and CD40
molecules, whereas CD11c+ pulmonary APCs from
the virus + BSA group and the virus group exhibited
increased expression of MHC class II and CD40
molecules (Fig. 2). Additionally, CD11c+ pulmonary
APCs from the virus + BSA group and the virus group
showed significantly higher ability to proliferate naïve
CD4+ T cells than those from the control group (Fig.
3). These data suggested that CD11c+ pulmonary
APCs from the control group are in an immature and
induce tolerance to innocuous antigens. In contrast,
Sato F et al.
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Fig. 5 The interaction between CD11c+ pulmonary APCs from the virus + 
BSA group and naïve CD4+ T cels showed the largest amounts of IL-10 
among those from the three groups. Naïve CD4+ T cels (4 × 105 cels/wel) 
from OT-I mice were cultured with CD11c+ pulmonary APCs (1 × 105 
cels/wel) in the presence of OVA (100 μg/ml) for 72 hours. Three to 10 
mice were used in each experimental group. Control group; white bar, Virus 
group; gray bar, Virus + BSA group; black bar. The culture supernatant was 
colected. (a) The amounts of IL-4 and IFN-γ were assessed by ELISA kit. 
(b) The amounts of IL-10 were assessed by ELISA kit. Data are representa-
tive of three independent experiments. * p < 0.05, **p < 0.01.
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CD11c+ pulmonary APCs from the virus + BSA group
and the virus group are in a mature state and lead to
active immune response of innocuous antigens. Mod-
erate expression of MHC class II molecules on
CD11c+ pulmonary APCs may be caused by large
amounts of IL-10 production by BSA antigen sensiti-
zation during the acute phase of influenza A viral in-
fection.
Cytokine production from APCs is a key factor for
the development or inhibition of immune re-
sponses.9,21 IL-10 has been reported to be a cytokine,
which is critical for the suppression of Th1 responses
and the induction of Th2 responses.28,29 CD11c+ pul-
monary APCs from the virus + BSA group and the vi-
rus group secreted large amounts of IL-10 after LPS
stimulation (Fig. 4). Both CD11c+ pulmonary APCs
may produce increased amounts of IL-10 secretion to
downmodulate the robust Th1 and cytotoxic T lym-
phocyte responses against influenza A viral infection.
Increased amounts of IFN-γ production by CD11c+
pulmonary APCs from the virus + BSA group could
play a role in the enhancement of allergic disease in
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vivo (Fig. 4), although IFN-γ is known to develop Th1
responses.9 In the mouse model of asthma with influ-
enza A viral infection, injection of neutralizing IFN-γ
mAb showed a decreased number of eosinophils into
the lungs after BSA antigen challenge and did not en-
hance the function of pulmonary DCs.12
It is well known that IL-10 is a Th2 cytokine as well
as an immunosuppressive cytokine, and also inhibits
MHC molecules on APCs.28,29 In this study, BSA anti-
gen sensitization during the acute phase of influenza
A viral infection enhanced IL-10 secretion from naïve
CD4+ T cells interacted with CD11c+ pulmonary
APCs (Fig. 5b). CD11c+ pulmonary APCs from the vi-
rus + BSA group had a high ability to proliferate naïve
CD4+ T cells (Fig. 3). CD11c+ pulmonary APCs from
the virus + BSA group showed moderate expression
levels of MHC class II molecules, whereas those from
the virus group showed high expression levels of
MHC class II molecules (Fig. 2). These data sug-
gested that the IL-10 production from the interaction
between CD11c+ pulmonary APCs from the virus +
BSA group and naïve CD4+ T cells would enhance
Th2 responses and decrease Th1 responses. Addi-
tionally, the moderate expression levels of MHC class
II molecules on CD11c+ pulmonary APCs from the vi-
rus + BSA group could polarize naïve CD4+ T cells to-
ward Th2 cells. A low expression of MHC-peptide
complex for TCR leads to Th2 cells, whereas a strong
TCR stimulation with increased expression of MHC-
peptide complex shows a preference for the induction
of Th1 cells.23 Indeed, BSA antigen sensitization dur-
ing the acute phase of influenza A viral infection
showed an increased number of eosinophils into the
lungs after BSA antigen challenge.
In summary, we demonstrated that BSA antigen
sensitization during the acute phase of influenza A vi-
ral infection induced CD11c+ pulmonary APCs to ex-
press moderate levels of MHC class II molecules and
large amounts of IL-10 secretion by the interaction
between CD11c+ pulmonary APCs and naïve CD4+ T
cells. IL-10 produced by the interaction may evoke
Th2 responses in the lungs with the downregulation
of Th1 responses. Thus, CD11c+ pulmonary APCs
from BSA antigen sensitization during the acute
phase of influenza A viral infection, at least in part,
play an important role in the induction of airway in-
flammation in our mice model.
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